Time-course of nigrostriatal degeneration in a progressive MPTP-lesioned macaque model of Parkinson's disease.
about
Dopamine transporter binding is unaffected by L-DOPA administration in normal and MPTP-treated monkeysExercise does not protect against MPTP-induced neurotoxicity in BDNF haploinsufficient mice.Transcriptional Factor NF-κB as a Target for Therapy in Parkinson's Disease.The parkinsonian mimetic, MPP+, specifically impairs mitochondrial transport in dopamine axonsAnimal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease.Modeling Parkinson's disease in primates: The MPTP modelOxidative stress and microglial cells in Parkinson's diseaseAxon degeneration in Parkinson's diseaseEstablished patterns of animal study design undermine translation of disease-modifying therapies for Parkinson's diseaseTRPC1-mediated inhibition of 1-methyl-4-phenylpyridinium ion neurotoxicity in human SH-SY5Y neuroblastoma cells.Validation of nigrostriatal positron emission tomography measures: critical limits.Perturbation of transcription factor Nur77 expression mediated by myocyte enhancer factor 2D (MEF2D) regulates dopaminergic neuron loss in response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).Molecular mechanisms of the conjugated alpha,beta-unsaturated carbonyl derivatives: relevance to neurotoxicity and neurodegenerative diseases.PE2I: a radiopharmaceutical for in vivo exploration of the dopamine transporter.Validation of midbrain positron emission tomography measures for nigrostriatal neurons in macaques.Glial Cell Line-Derived Neurotrophic Factor Gene Delivery in Parkinson's Disease: A Delicate Balance between Neuroprotection, Trophic Effects, and Unwanted Compensatory Mechanisms.The significance of defining preclinical or prodromal Parkinson's disease.Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson's disease.Dissecting the role of Engrailed in adult dopaminergic neurons--Insights into Parkinson disease pathogenesisProtective effects of a polysaccharide from Spirulina platensis on dopaminergic neurons in an MPTP-induced Parkinson's disease model in C57BL/6J mice.Metabolic activity of the subthalamic nucleus in a primate model of L-dopa-unresponsive parkinsonism.MPTP Induces Systemic Parkinsonism in Middle-Aged Cynomolgus Monkeys: Clinical Evolution and Outcomes.Evidence for Sprouting of Dopamine and Serotonin Axons in the Pallidum of Parkinsonian Monkeys.
P2860
Q27316473-68AD56D6-4749-4529-9C99-0D67E901D95DQ34389461-DE75309E-96C7-4C48-9EB1-8665DFC92A3DQ34983243-A9CE7886-F134-40D4-AB8A-E409F0FEA9ADQ35119950-8EE3151A-111E-458E-97BA-85B9CF5E8615Q35589979-F60F6956-2F0E-4865-BF63-112503A0EB8AQ35765748-B12B5553-A0F0-42F7-8AC9-24414F729F9AQ35876266-840C3ADA-7724-4EDE-8C1B-4A5D0910CE06Q35923102-EBF182B2-6C64-4304-96B0-902E46F4CB51Q36275707-9EEE84C5-B494-4C85-8172-F5AD94CC6F9DQ36747920-CE8384CA-F70C-475E-912E-2EBD11F39DC1Q36780857-904D8FF8-FD3F-48AA-9BBE-81D54CECA1EBQ36850316-1BB93CEE-E8AD-4DAC-A3A3-22894EA34C8CQ37033629-9A601142-2ABC-44FD-B4E0-2A7B8229B497Q37164698-21AEEB0D-9533-41BF-BBA0-4FFEFD2DF63FQ37238890-327AA121-B661-4719-9308-BA2261D3E480Q37742852-EF1893C2-3AB4-4BFC-BAF5-0545086EEF79Q38003068-B1C83E1C-12E6-47B2-B4CC-FE962188E241Q38598375-77EB1D05-BADB-4529-B21C-3AF43DC7B3F0Q38605280-ACAC33BE-9BE9-40E9-97C0-990B92F1A3C9Q39491561-C77B00D0-6D57-4C76-A049-566490C12459Q42920402-7EAE3B39-A2BC-4471-88DA-1DD5461161C5Q49197319-6FAB665C-D343-4204-BAA1-46EFFA187F26Q55002495-47B0AE56-C565-41DA-9FFD-297B7A6D0834
P2860
Time-course of nigrostriatal degeneration in a progressive MPTP-lesioned macaque model of Parkinson's disease.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Time-course of nigrostriatal d ...... model of Parkinson's disease.
@ast
Time-course of nigrostriatal d ...... model of Parkinson's disease.
@en
type
label
Time-course of nigrostriatal d ...... model of Parkinson's disease.
@ast
Time-course of nigrostriatal d ...... model of Parkinson's disease.
@en
prefLabel
Time-course of nigrostriatal d ...... model of Parkinson's disease.
@ast
Time-course of nigrostriatal d ...... model of Parkinson's disease.
@en
P50
P356
P1476
Time-course of nigrostriatal d ...... model of Parkinson's disease.
@en
P2093
Caroline Prunier
Christian E Gross
P2888
P304
P356
10.1385/MN:28:3:209
P577
2003-12-01T00:00:00Z
P6179
1015551492